# OnCo record impress-trial (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/impress-trial/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "impress-trial", "NCT01072981" ;
  schema:name "IMPRESS (algenpantucel-L)"@en ;
  schema:description "The largest vaccine trial after pancreatic cancer surgery found that algenpantucel-L added nothing to standard chemotherapy."@en ;
  schema:url <https://onco.cc/trials/impress-trial/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01072981> ;
  onco:status "negative" ;
  onco:phase "3" ;
  schema:startDate "2010-04" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:technologies <https://onco.cc/technologies/shared-antigen-vaccine/> ;
  onco:drugs <https://onco.cc/drugs/algenpantucel-l/>, <https://onco.cc/drugs/gemcitabine/> ;
  onco:companies <https://onco.cc/companies/newlink-genetics/> ;
  onco:terms <https://onco.cc/terms/vaccines-and-oncolytic-viruses/> .
